Table 1.
Viala | Target organisms | Analysisb | Meanc | I2e | Tf |
---|---|---|---|---|---|
C1 | C. coli | mCCDA, 37°C, 48 h | 3.7 x 105 | 8.1 | 1.9 |
C2 | S. Stockholm | BHI agar, 37°C, 24 h | 4.1 x 104d | 2.1 | 1.6 |
C2 | Y. enterocolitica O:3/BT4 | BHI agar, 37°C, 24 h | 9.9 x 104d | 0.8 | 1.3 |
C3 | S. Enteritidis | BHI agar, 37°C, 24 h | 6.0 x 104d | 0.6 | 1.2 |
C3 | C. jejuni | mCCDA, 37°C, 48 h | 5.6 x 104 | 0.5 | 1.2 |
C5 | Y. enterocolitica BT1A | BHI agar, 37°C, 24 h | 1.2 x 105 | - | - |
Five vials of C1, C3 and C4 and ten vials of C2 and C5 were analyzed in duplicate.
mCCDA, Modified Charcoal Cephoperazone Deoxycholate Agar; d BHI, Brain Heart Infusion.
Concentration mean in cfu/mL.
From analysis of a parallel sample mixture.
Index of dispersion.
Test of reproducibility.